The Discounted Cash Flow (DCF) valuation of Zhejiang Shengda Bio-Pharm Co Ltd (603079.SS) is 10.00 CNY. With the latest stock price at 17.54 CNY, the upside of Zhejiang Shengda Bio-Pharm Co Ltd based on DCF is -43.0%.
Based on the latest price of 17.54 CNY and our DCF valuation, Zhejiang Shengda Bio-Pharm Co Ltd (603079.SS) is a sell. selling 603079.SS stocks now will result in a potential gain of 43.0%.
| Range | Selected | |
| WACC / Discount Rate | 9.2% - 11.3% | 10.2% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 7.83 - 13.89 | 10.00 |
| Upside | -55.3% - -20.8% | -43.0% |